A patent in­fringe­ment let­ter can ar­rive when a prod­uct launch, fund­ing round or ma­jor cus­tomer ne­go­ti­a­tion is al­ready un­der way. The first re­sponse can ma­te­ri­al­ly af­fect the company’s le­gal ex­po­sure, ne­go­ti­at­ing po­si­tion and free­dom to con­tin­ue trad­ing. Know­ing how to re­spond to a patent in­fringe­ment claim means con­trol­ling the facts be­fore mak­ing ad­mis­sions, tech­ni­cal ex­pla­na­tions or com­mer­cial promises.

An al­le­ga­tion is not proof of in­fringe­ment. Equal­ly, it should nev­er be treat­ed as rou­tine cor­re­spon­dence. The patent hold­er may have a strong, care­ful­ly pre­pared case, or may be test­ing whether your busi­ness has the re­sources and ev­i­dence to chal­lenge its po­si­tion. A dis­ci­plined tech­ni­cal and le­gal as­sess­ment cre­ates the ba­sis for a de­fen­si­ble response.

How to re­spond to a patent in­fringe­ment claim: first actions

Read the let­ter close­ly, but do not re­ply sub­stan­tive­ly on the same day. Iden­ti­fy the patents, ter­ri­to­ries, prod­ucts or process­es ac­cused, re­quest­ed reme­dies, dead­lines and any de­mand to pre­serve doc­u­ments. Con­firm whether the cor­re­spon­dence is a pre­lim­i­nary ap­proach, a for­mal cease-and-de­sist let­ter, an in­vi­ta­tion to take a li­cence, or a step con­nect­ed to litigation.

Put a small re­sponse team in place im­me­di­ate­ly. It should nor­mal­ly in­clude a se­nior com­mer­cial de­ci­sion-mak­er, the rel­e­vant en­gi­neer­ing lead, in­ter­nal le­gal coun­sel where avail­able, and ex­ter­nal patent lit­i­ga­tion coun­sel in the ju­ris­dic­tions con­cerned. Keep in­ter­nal cir­cu­la­tion lim­it­ed. Spec­u­la­tive emails, in­for­mal prod­uct com­par­isons and untest­ed opin­ions can lat­er be­come un­help­ful documents.

Pre­serve rel­e­vant ev­i­dence. This in­cludes de­sign files, source code records where rel­e­vant, test data, bills of ma­te­ri­als, sup­pli­er spec­i­fi­ca­tions, prod­uct man­u­als, sales in­for­ma­tion and dat­ed de­vel­op­ment records. Do not al­ter, delete or recre­ate doc­u­ments. A clear preser­va­tion process pro­tects the busi­ness and al­lows tech­ni­cal ex­perts to re­con­struct what was made, when, and how it operates.

The dead­line de­serves at­ten­tion, but ur­gency should not pro­duce an un­sup­port­ed ad­mis­sion. If more time is need­ed for a prop­er as­sess­ment, coun­sel may seek an ex­ten­sion or ac­knowl­edge re­ceipt with­out con­ced­ing li­a­bil­i­ty. The ap­pro­pri­ate ap­proach de­pends on the fo­rum, the word­ing of the al­le­ga­tion and the claimant’s lit­i­ga­tion posture.

Es­tab­lish what is ac­tu­al­ly be­ing alleged

A patent is de­fined by its claims, not by its ti­tle, ab­stract or broad com­mer­cial de­scrip­tion. The cen­tral ques­tion is whether a spe­cif­ic prod­uct, method or com­po­nent falls with­in the scope of at least one valid claim in force in a rel­e­vant territory.

Start by build­ing an ac­cu­rate prod­uct pic­ture. Prod­uct names are of­ten too broad for this pur­pose. Es­tab­lish the ex­act ver­sions sold or of­fered, their re­lease dates, tech­ni­cal con­fig­u­ra­tions, op­tion­al fea­tures, man­u­fac­tur­ing routes and mar­kets. A claim may con­cern one nar­row fea­ture rather than the en­tire de­vice. Con­verse­ly, a fea­ture re­moved in a new­er ver­sion may still ex­ist in lega­cy stock or in­stalled systems.

Check the le­gal sta­tus of every as­sert­ed patent. Con­firm own­er­ship, ter­ri­to­r­i­al cov­er­age, ex­piry dates, fee sta­tus, claim amend­ments and any op­po­si­tion, re­vo­ca­tion or lim­i­ta­tion pro­ceed­ings. A grant­ed US patent, for ex­am­ple, does not au­to­mat­i­cal­ly cre­ate ex­po­sure for man­u­fac­ture or sales con­fined to the UK or Eu­rope. The rel­e­vant acts of man­u­fac­ture, use, of­fer for sale, im­por­ta­tion and sale must be mapped against the rights in force.

Cre­ate a claim-by-claim tech­ni­cal analysis

The most use­ful ear­ly work is usu­al­ly a claim chart. This maps each lim­i­ta­tion of an as­sert­ed in­de­pen­dent claim, and po­ten­tial­ly rel­e­vant de­pen­dent claims, to ev­i­dence from the ac­cused prod­uct or process. It forces pre­ci­sion where com­mer­cial cor­re­spon­dence is of­ten de­lib­er­ate­ly broad.

The ex­er­cise should dis­tin­guish be­tween con­firmed facts, rea­son­able in­fer­ences and un­knowns. En­gi­neers may know that a prod­uct achieves a par­tic­u­lar re­sult, but the patent claim may re­quire a par­tic­u­lar tech­ni­cal mech­a­nism to achieve it. That dif­fer­ence can be de­ci­sive. A prod­uct that looks sim­i­lar, serves the same cus­tomer need or com­petes in the same mar­ket does not nec­es­sar­i­ly infringe.

Ev­i­dence should be trace­able. Ref­er­ence draw­ings, pho­tographs, soft­ware doc­u­men­ta­tion, mea­sure­ments, man­u­fac­tur­ing records and test pro­to­cols rather than re­ly­ing on rec­ol­lec­tion. If the al­le­ga­tion con­cerns a customer’s com­bi­na­tion of your com­po­nent with oth­er equip­ment, de­ter­mine who per­forms each claimed step and whether the le­gal re­quire­ments for in­di­rect in­fringe­ment are met in the ap­plic­a­ble jurisdiction.

This analy­sis also iden­ti­fies prac­ti­cal de­sign-around op­tions. A mi­nor change may re­move a re­quired claim fea­ture, but only if it is tech­ni­cal­ly real, prop­er­ly doc­u­ment­ed and com­mer­cial­ly work­able. Do not as­sume that chang­ing ter­mi­nol­o­gy, di­men­sions or a non-es­sen­tial vi­su­al fea­ture avoids the claim.

Test va­lid­i­ty and en­force­abil­i­ty in parallel

A claim can be tech­ni­cal­ly rel­e­vant to your prod­uct and still be vul­ner­a­ble. Pri­or art may show that the claimed in­ven­tion was not new or did not in­volve an in­ven­tive step. Oth­er is­sues may arise from in­suf­fi­cient dis­clo­sure, added sub­ject mat­ter, lack of en­ti­tle­ment or de­fects in the patent’s pros­e­cu­tion his­to­ry, de­pend­ing on the jurisdiction.

Pri­or-art search­ing should be tar­get­ed, not mere­ly broad. The best ma­te­r­i­al may sit in old­er tech­ni­cal pa­pers, cat­a­logues, man­u­als, con­fer­ence pre­sen­ta­tions, pub­lic use ev­i­dence or patents from ad­ja­cent in­dus­tries. Dates, pub­lic avail­abil­i­ty and the pre­cise tech­ni­cal dis­clo­sure mat­ter. An un­dat­ed in­ter­net im­age or a gen­er­al state­ment that a con­cept was known rarely pro­vides a re­li­able defence.

Va­lid­i­ty as­sess­ment is not sim­ply a lit­i­ga­tion ex­er­cise. Strong in­va­lid­i­ty ma­te­r­i­al can change li­cence dis­cus­sions, sup­port a re­quest to nar­row the al­le­ga­tion, or jus­ti­fy a more con­fi­dent com­mer­cial po­si­tion. It may also re­veal that chal­leng­ing the patent would be ex­pen­sive and un­cer­tain, mak­ing a ne­go­ti­at­ed route more sensible.

Choose the re­sponse that pro­tects the business

Once the tech­ni­cal facts and le­gal po­si­tion are clear­er, the re­sponse should be aligned with com­mer­cial pri­or­i­ties. There is no sin­gle cor­rect out­come. A com­pa­ny may deny in­fringe­ment, re­quest de­tailed par­tic­u­lars, chal­lenge va­lid­i­ty, ne­go­ti­ate a stand­still, mod­i­fy a prod­uct, seek a li­cence, or pre­pare for lit­i­ga­tion. Sev­er­al of these steps may run in parallel.

A de­nial should be spe­cif­ic enough to be cred­i­ble but should not dis­close un­nec­es­sary con­fi­den­tial de­tail. If non-in­fringe­ment de­pends on an in­ter­nal ar­chi­tec­ture, coun­sel and tech­ni­cal ad­vis­ers should de­cide what can be safe­ly stat­ed and what ev­i­dence should be re­tained for lat­er use. If a de­sign-around is be­ing eval­u­at­ed, avoid pre­sent­ing it as an ad­mis­sion that the ex­ist­ing prod­uct infringes.

Li­cens­ing can be com­mer­cial­ly ra­tio­nal where the patent is strong, the mar­ket is strate­gi­cal­ly valu­able and re­design would dis­rupt cus­tomers or reg­u­la­to­ry ap­provals. How­ev­er, the scope of any li­cence re­quires close scruti­ny. It should ad­dress the rel­e­vant patent fam­i­ly, ter­ri­to­ry, prod­ucts, sup­ply chain, past sales, fu­ture de­vel­op­ments and rights to chal­lenge where per­mit­ted. A quick set­tle­ment that leaves crit­i­cal prod­uct vari­ants un­cov­ered can cre­ate a sec­ond dispute.

Where the al­leged risk is ma­te­r­i­al, mod­el the op­er­a­tional con­se­quences along­side the le­gal ones. Con­sid­er in­ven­to­ry, cus­tomer com­mit­ments, sup­pli­er de­pen­den­cies, prod­uct ap­provals, in­sur­ance no­ti­fi­ca­tion re­quire­ments and in­vestor com­mu­ni­ca­tions. The cost of a tem­po­rary sales in­ter­rup­tion may ex­ceed the le­gal cost of a fast tech­ni­cal so­lu­tion. In oth­er cas­es, con­ced­ing too ear­ly may cre­ate a dam­ag­ing prece­dent for a grow­ing port­fo­lio or prod­uct line.

Keep tech­ni­cal, le­gal and com­mer­cial work coordinated

Patent dis­putes of­ten be­come hard­er be­cause the en­gi­neer­ing team, man­age­ment and lawyers work from dif­fer­ent ver­sions of the facts. Es­tab­lish one con­trolled fac­tu­al record and ap­point a per­son re­spon­si­ble for up­dates. Record de­ci­sions, as­sump­tions and prod­uct changes with dates.

Tech­ni­cal patent analy­sis should sup­port le­gal coun­sel, not re­place it. Patent at­tor­neys and lit­i­ga­tion lawyers ad­vise on le­gal in­ter­pre­ta­tion, pro­ce­dure and cor­re­spon­dence. Spe­cial­ist en­gi­neer­ing-led analy­sis pro­vides the de­tailed ev­i­dence need­ed to test whether the claims match the ac­tu­al tech­nol­o­gy. TIPAG sup­ports this work with struc­tured in­fringe­ment analy­sis, pri­or-art as­sess­ment and tech­ni­cal ev­i­dence suit­able for in­formed le­gal and com­mer­cial decisions.

Com­mu­ni­ca­tions with cus­tomers, dis­trib­u­tors and sup­pli­ers re­quire par­tic­u­lar care. Do not cir­cu­late the al­le­ga­tion un­nec­es­sar­i­ly or make as­sur­ances that have not been test­ed. Where a cus­tomer has raised the is­sue, pro­vide a mea­sured re­sponse based on ver­i­fied facts and agreed le­gal strategy.

The ob­jec­tive is not to pro­duce the quick­est let­ter. It is to pre­serve room to ma­noeu­vre while the com­pa­ny es­tab­lish­es what the patent cov­ers, what the prod­uct does and which com­mer­cial route best pro­tects the busi­ness. A calm, ev­i­dence-led re­sponse at the out­set gives man­age­ment op­tions when they mat­ter most.